894769-82-5

Basic information

• Product Name: tert-butyl 4-(4-fluorobenzyl)-4-formylpiperidine-1-carboxylate
• Synonyms: tert-butyl 4-(4-fluorobenzyl)-4-formylpiperidine-1-carboxylate
• CAS NO: 894769-82-5
• Molecular Weight: 321.392
• Mol File: 894769-82-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-(4-fluorobenzyl)-4-formylpiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(4-fluorobenzyl)-4-formylpiperidine-1-carboxylate(894769-82-5)
• EPA Substance Registry System: tert-butyl 4-(4-fluorobenzyl)-4-formylpiperidine-1-carboxylate(894769-82-5)

Safety Data

• Hazardous Substances Data: 894769-82-5(Hazardous Substances Data)

Upstream product

• 917755-78-3 tert-butyl 4-(4-fluorobenzyl)-4-(hydroxymethyl)piperidine-1-carboxylate 
• 124443-68-1 1-tert-Butyl 4-methyl piperidine-1,4-dicarboxylate 
• 79-37-8 oxalyl dichloride 
• 7087-68-5 N-ethyl-N,N-diisopropylamine 
• 906329-46-2 1-tert-butyl 4-methyl 4-(4-fluorobenzyl)piperidine-1,4-dicarboxylate 
• 459-46-1 4-Fluorobenzyl bromide 
• 894769-77-8 tert-butyl 4-cyano-4-(4-fluorobenzyl)piperidine-1-carboxylate 

Downstream Products

• 894770-00-4 4-ethenyl-4-[(4-fluorophenyl)methyl]-1-piperidinecarboxylic acid 1,1-dimethylethyl ester 
• 894769-96-1 4-[[(2-ethoxy-2-oxoethyl)amino]methyl]-4-[(4-fluorophenyl)methyl]-1-piperidinecarboxylic acid 1,1-dimethylethyl ester 

Relevant articles and documents

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.

PIPERIDINE DERIVATIVES AS ANTAGONISTS OF THE CC CHEMOKINE RECEPTOR CCR1 AND THEIR USE AS ANTI-INFLAMMATORY AGENTS

Piperidine derivatives of the following formulae (I) and (II) and their pharmaceutically acceptable salts, which are functional antagonists of the CC chemokine receptor CCR1 and are thus useful as anti inflammatory agents, a pharmaceutical compositions co